BIOPSY-26: Establish AUBRAI Operational Setup, Multisig & Tokenomics

TL;DR

• Approve the launch of Aubrai through the BIO Launchpad as the first agent token to utilize Bio Protocol's new launch infrastructure.

• Designate Aubrai as a pilot implementation of Molecule Protocol V2 for DeSci IP→RWA workflows, establishing the framework for future scientific IP tokenization.

• Support the creation of a Swiss Association (Verein) to execute DAO decisions off-chain, following the proven governance model established by VitaDAO.

• Establish a 4/6 multisig with representatives from VitaDAO, BIO, Molecule, Aubrai, and an Aubrai guardian to ensure decentralized operational control.

• Ratify $AUBRAI tokenomics: 2,000,000 total supply with allocations & vesting as detailed below. No treasury spend requested; this is an operational ratification enabling launch.

---

Motivation

Aubrai aims to operationalize an AI-forward DeSci project that aligns with BIO’s ecosystem and VitaDAO’s longevity mission. To move from concept to execution, we need:

1. A legally capable executor for DAO votes,
2. Governance-aligned treasury controls, and
3. A clear token distribution/vesting plan that aligns incentives across stakeholders.

Why Molecule Protocol V2 now? V2 provides a bridge from tokenized scientific/IP participation to institution-grade RWAs, enhancing compliance and institutional appeal while preserving decentralization.

Why a Swiss Association? The Swiss Verein model is already in production within VitaDAO to implement community decisions and steward IP/ops—minimizing execution risk by following a proven pattern.

---

Specification

1) Operational Setup

• IP Owner: An American LLC will be created to serve as the owner and holder of all IP rights linked to Aubrai, including those from the RMR2 study. This will be the pilot implementation of Molecule Protocol V2 creating an IP → equity/RWA bridge with compliant paths for future revenue distribution.

• DAO executor: Form an Swiss Association (Verein) as the off-chain counterparty executing Snapshot-approved decisions; bylaws bind the members to DAO votes (within legal bounds), mirroring VitaDAO’s Swiss Association model.

2) Multisig Setup (4-of-6)

Create a 4/6 Safe with the following signers:

• VitaDAO representatives: as co-initiators and core developers of Aubrai, VitaDAO will designate 2 signers to participate in the Multisig.

• BIO: as co-initiators and core liquidity manager, BIO will designate 1 signer to participate in the Multisig.

• Molecule: as core IP managers, Molecule will designate 1 signer to participate in the Multisig.

• Aubrai Agent Wallet Governance: The Aubrai agent will participate autonomously in the Multisig with its own EOA wallet:

• Architecture: Single-signer EOA created via Coinbase Developer Portal (CDP) API, with keys secured in Coinbase's Trusted Execution Environment. Private keys remain inaccessible to team and agent.

• Access Control: CDP API keys enforce policy-based authorization for specific actions (POI minting, token burns/transfers).

• Launch Scope: Agent initially restricted to minting Proof of Invention tokens upon meeting hypothesis quality thresholds.

• Future Expansion: Progressive decentralization roadmap enables token holders to approve expanded agent capabilities including autonomous transfers, burns, and additional on-chain operations.

• Guardian (Aubrai Association): 1 signer

3) Tokenomics — $AUBRAI (Total Supply: 2,000,000)

Allocation	%	Tokens	Vesting / Liquidity
Launchpad (public sale)	20.0%	400,000	Sold to the public via the BIO Launchpad framework
Liquidity Pool	6.0%	120,000	Seed DEX liquidity and support market health
Treasury (DAO)	15.0%	300,000	Community incentives & strategic initiatives; held in DAO-controlled multisig
Initial Funders (RMR2 study)	20.1%	402,000	50% liquid at TGE; 50% vesting linear over 4 years
LEVF	10.0%	200,000	4-year vesting with 1-year cliff
VitaDAO	22.0%	440,000	50% liquid at TGE; 50% vesting linear over 4 years
BIO	6.9%	138,000	Fully liquid at TGE

• Vesting contracts will be transparent (on-chain), with verifiable cliff/linear schedules at deployment.

• Any post-TGE emissions or changes require separate governance approval.

4) Token & Launch Mechanics (at a glance)

• Token Launch: AUBRAI will launch through Bio Protocol's new agent launchpad, deploying as an ERC-20 token that leverages Bio's established launch infrastructure and deployment framework (docs.bio.xyz)

• Token Generation Event: TGE will follow the successful completion of the Launchpad raise and initial liquidity pool deployment. Vesting smart contracts will be deployed at the moment of launch finalization, ensuring all token distributions follow predetermined vesting schedules from day one.

• Liquidity Provisioning: The Bio Launchpad will seed initial liquidity pools with 120,000 $AUBRAI (6% of supply) as specified in this proposal's liquidity plan. Any future adjustments to liquidity provisions will be governed by AUBRAI token holders through the project's governance framework.

• Bio Protocol First Buy Rights: Bio Protocol will be granted the right to purchase AUBRAI tokens through the liquidity pool as part of the initial liquidity deployment transaction, enabling the protocol to utilize purchased tokens for liquidity management and user rewards within the Bio ecosystem.

---

Implementation & Timeline

1. Association formation (Swiss Verein): draft articles binding members to DAO Governance.

2. LLC formation: establish entity and assign IP rights from RMR2.

3. Multisig deployment: create 4/6 Safe as specified above.

4. Token contracts: deploy $AUBRAI (ERC-20 on Base), vesting escrows for LEVF, VitaDAO, Initial Funders (50% portion), and any lockups as defined here.

5. Implementation Timeline: Complete sale parameter configuration with BIO Launchpad team, conduct the public token sale through the launchpad platform, and upon successful conclusion, distribute AUBRAI tokens to participants according to the allocation schedule outlined in this proposal.

6. LP seeding: deposit 120,000 $AUBRAI + paired asset per plan.

---

Success Criteria

• Aubrai Swiss Association formed; bylaws published.

• American LLC formed; IP rights assigned.

• Multisig live.

• $AUBRAI allocations distributed and vesting contracts deployed with logic visible on-chain.

• Launchpad completed; LP seeded; treasury under DAO control.

---

References

• Molecule Protocol V2 — legal/technical framing for IP→RWA and milestone-tied on-chain governance. Molecule

• BIO Launchpad docs — phases and mechanics for curation/funding/liquidity. docs.bio.xyz

• VitaDAO Swiss Association precedents — Vitality Now Association (Swiss Verein) as legal steward. Governance Forum | VitaDAO

• Swiss Association (Verein) background — legal wrapper context for DAOs. Wikipedia